GET DAILY SIGNALSWhy Is Quanome Technologies (QNME) Stock Down -8.11% Today?
Key Takeaways
- QNME shares fell roughly 8.11% to about $0.34, down from a prior close of $0.37.
- The primary catalyst was a newly announced all-stock investment in QAI Labs that will issue about 6.54 million new shares, diluting existing holders.
- Secondary pressure came from the stock's penny-stock volatility, a going-concern warning, and Nasdaq minimum-bid compliance risk.
- The move reflects caution around speculative micro-cap quantum and AI names rather than broad-market weakness.
- Traders are watching deal closing conditions, potential future share issuance, and any progress toward Nasdaq compliance.
- For more detail on valuation, results, and outlook, explore Price Targets, Earnings, and Forecast pages.
- To see which strategies are outperforming right now, visit Trending AI Robots.
Opening Summary
Quanome Technologies, Inc. (QNME), a Nevada-incorporated company headquartered in Itasca, Illinois, trades on the Nasdaq Capital Market. The company rebranded from Lakeside Holding Limited in August 2026 and now focuses on quantum computing, artificial intelligence, advanced simulation, and intelligent systems. On Monday, shares dropped approximately 8.11% to about $0.34 from a prior close of $0.37. The decline came as investors weighed the dilution implied by a newly disclosed all-stock investment in QAI Labs, an early-stage AI drug-discovery company.
Catalyst Breakdown: A Dilutive All-Stock Deal
The session's headline was Quanome's announcement that it had entered into a definitive agreement, dated November 4, 2026, to take an approximately 5% stake in QAI Labs Ltd., the developer of the NOVA-3 AI-enabled multi-specific antibody discovery platform. Under the all-stock transaction, QAI Labs will issue 31,579 new shares to Quanome, while Quanome will issue 6,541,236 new shares of its common stock to QAI Labs.
That issuance represents roughly 19% of Quanome's outstanding shares immediately before the transaction and approximately 15.97% after it. For existing shareholders, the structure carries an immediate dilution signal, a key reason the market reacted negatively despite management framing the deal as an advancement of its "Quantum Life Sciences" strategy. The parties assigned the consideration shares a negotiated transaction value of about $5.0 million, implying an equity valuation near $100 million for QAI Labs.
Secondary Drivers: Penny-Stock Risk and Balance-Sheet Concerns
Beyond the dilution, QNME remains a low-priced, thinly capitalized stock with elevated downside sensitivity to any incremental share issuance. The company's most recent annual filing disclosed a going-concern qualification, recurring net losses, and a cash position that had fallen sharply from prior levels. Management has also flagged the risk that it may need additional equity financing, which traders often read as a precursor to further dilution.
The stock has also been trading below the Nasdaq's $1.00 minimum bid-price requirement, with a stated deadline to regain compliance in early 2027. That overhang, combined with the inherently speculative nature of early-stage quantum and AI ventures, made the stock vulnerable to selling pressure once the share-issuance terms became public.
Market Context and Trading Activity
The decline was company-specific rather than a reflection of broad-market sentiment, as major U.S. equity indices traded without a comparable catalyst for small-cap technology names. QNME has experienced extreme volatility since its rebranding, including multi-million-share volume spikes tied to announcements around GPU purchases and AI-computing contracts. Monday's trading was more subdued, consistent with a stock settling back as investors repriced the cost of a dilutive transaction rather than responding to fresh momentum.
What Comes Next for QNME
Investors will be watching whether the QAI Labs transaction closes by its stated conditions and deadlines, and whether Quanome discloses additional financing arrangements that could further dilute shareholders. The company's ability to fund its committed GPU-server purchases and bring its XDT AI-computing hub into service remains an open question that will likely influence sentiment. Nasdaq minimum-bid compliance is another key risk, with a possible reverse stock split cited as a potential remedy. Upcoming filings, earnings releases, and any progress on revenue-generating milestones will be closely monitored, though the company's pre-commercial initiatives carry significant execution uncertainty.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore approaches aligned with their own objectives. Explore the Trending AI Robots page to see which strategies are currently leading the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
QNME's RSI Oscillator recovers from overbought zone
The 10-day RSI Indicator for QNME moved out of overbought territory on October 09, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 6 instances where the indicator moved out of the overbought zone. In 6 of the 6 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QNME as a result. In 43 of 47 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for QNME turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In 23 of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
QNME moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for QNME crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QNME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for QNME entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +3.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where QNME advanced for three days, in 92 of 104 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.943) is normal, around the industry mean (2.483). P/E Ratio (-1.621) is within average values for comparable stocks, (7.339). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.110). Dividend Yield (0.000) settles around the average of (0.020) among similar stocks. P/S Ratio (0.242) is also within normal values, averaging (2.034).
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. QNME’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNME’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry OtherTransportation
Advertisement